Report Categories
View AllRecent Articles
View All
EQIX Equinix revenue climbs 54 YoY to 92B despite slight EPS miss shares edge higher on AI momentum
Amarin AMRN Stock Research Q4 2025 Profit Exceeds Views
How AGNC D Pref AGNCM earnings power compares to its price 004 20260510
ConnectOne CNOB Stock Foreign Investment 235 20260418
2026 CNBC Disruptor 50 AIDriven Business Models Propel Combined Valuation to 24 Trillion
Tracking the Economic Effects of Tariffs What Recent Data Suggests
NanoXplore Appoints CEO Rocco Marinaccio to Board of Directors
Nanobiotix NBTX Slips 673 Testing 4880 Support 20260515
Agora API Drops 078 Key Support at 362 20260520
DR Horton DHI Q1 2026 Earnings Shine Revenue Growth Fuels Beat
Blackstone and ESR Eye Expansion in Japans Warehouse Market
Mobile Infrastructure BEEP Q1 2026 Earnings NarrowerThanExpected Loss and Surprise EPS Beat
India Plans Overhaul of Tax Administration to Ensure Smooth Goods and Services Tax Rollout
X Owned by Elon Musk Fined A650000 by Australia for Child Protection Compliance Failures
Compass COMP Stock Under 15 Market Perspectives and Key Considerations
Surge in LongDated Treasury Yields Forces Bond Investors to Rethink RiskFree Status
Surging Gas Prices Disproportionately Strain LowerIncome Households New York Fed Study Finds
Nifty 50s LongTerm Track Record Offers Reassurance to Foreign Investors Amid Market Headwinds
NMI Holdings Q1 2026 Earnings EPS Beats Estimates Stock Declines Slightly
SLDP Q1 2026 Earnings Solid Power Beats EPS Estimates by a Wide Margin PreRevenue Status Maintained
Stifel Q1 2026 Earnings Modest EPS Beat Amid Market Challenges Shares Edge Lower
TCPC Q1 2026 Earnings EPS Beats Estimates by Over 10
CBNA Q1 2026 Earnings EPS Surpasses Estimates Despite Stock Pullback
Geopolitical Tensions Rise as FarRight Israeli Ministers Actions Draw International Condemnation
Supernus Pharmaceuticals SUPN Q1 2026 Earnings EPS 060 Beats Estimates
Riverview Bancorp RVSB Q1 2026 Earnings Soft Quarter Raises Questions
Star STRR Slips 331 Testing 929 Support 20260520
Best Buy BBY Crushes Q1 2026 Estimates EPS 261 Tops Views
Kairos Pharma KAPA Posts Weak Q1 2026 Misses on Both Top and Bottom Lines